N-(4-Hydroxyphenyl)retinamide induces apoptosis in T lymphoma and T Lymphoblastoid leukemia cells

References

• Formelli F., Clerici M., Campa T., DiMauro M. G., Magni A., Mascotti G., Moglia D., DePalomo G., Costa A., Veronesi U. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J. Clin. Oncol. 1993; 11: 2036–2042
   PubMed Web of Science ®Google Scholar
• Costa A., Formelli F., Chiesa F., Decensi A., DePalo G., Veronesi U. Prospect of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res. 1994; 54: 2032s–2037s
   PubMed Web of Science ®Google Scholar
• Moon R. C., Thompson H. C., Becci P. J., Grubbs C. J., Gander R. J., Newton D. L., Smith J. M., Phillips S. L., Henderson W. R., Mullen L. T., Brown C. C., Sporn M. B. N-(4-hydroxphyenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res. 1979; 39: 1339–1346
   PubMed Web of Science ®Google Scholar
• Mariotti A., Marcora E., Bunone G., Costa A., Veronesi U., Pierotti M. A., Valle G. D. N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. J. Natl. Cancer Inst. 1994; 86: 1245–1247
   PubMed Web of Science ®Google Scholar
• DeVinci A., Geido E., Infusini E., Giaretti W. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(hydroxyphenyl)retinamide (HPR) is a synthetic retinoid with anti-cancer properties and lower toxicity than all-trans retinoic acid (RA). Int. J. Cancer 1994; 3: 422–426
   Web of Science ®Google Scholar
• Delia D., Aiello A., Lombardi L., Pelicci P. G., Grignani F., Jr., Grignani F., Formelli F., Menard S., Costa A., Veronesi U., Pierotti M. A. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res. 1993; 53: 6036–6041
   PubMed Web of Science ®Google Scholar
• Delia D., Aiello A., Formelli F., Fontanella E., Costa A., Miyashita T., Reed J. C., Pierotti M. A. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulation bcl-2. Blood 1995; 85: 359–367
   PubMed Web of Science ®Google Scholar
• Sheikh M. S., Shao Z.-M., Li X.-S., Ordonez J. V., Conely B. A., Wu S., Quick T., Niles R. M., Fontana J. A. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent path-ways in human breast carcinoma. Carcinogenesis 1995; 16: 2477–2486
   PubMed Web of Science ®Google Scholar
• Norman M. R., Thompson E. B. Characterization of a glucocorticoid-sensitive human lymphoid cell line. Cancer Res. 1977; 37: 3785–3791
   PubMedGoogle Scholar
• Harmon J. M., Thompson E. B. Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-C7. Mol. Cell. Biol. 1981; 1: 512–521
   PubMed Web of Science ®Google Scholar
• Zawydiwski R., Harmon J. M., Thompson E. B. Glucocorticoid-resistant human acute lymphoblastic leukemia cell line with functional receptor. Cancer Res. 1983; 43: 3865–3873
   PubMed Web of Science ®Google Scholar
• Thompson E. A., Jr. Properties of a cell-culture line derived from lymphosarcoma P1798. Mol. Cell. Endocrinol. 1979; 17: 95–102
   Web of Science ®Google Scholar
• Lucas K. L., Barbour K. W., Housley P. R., Thompson E. A., Jr. Biochemical and molecular characterization of glucocorticoid receptor of lymphosarcoma P1798 variants. Mol. Endocrinol. 1988; 2: 291–299
   PubMed Web of Science ®Google Scholar
• Thompson E. A., Jr. Glucocorticoid insensitivity of P1798 lymphoma cells is associated with production of a factor that attenuates the lytic response. Cancer Res. 1991; 51: 5551–5556
   PubMed Web of Science ®Google Scholar
• Mishell B., Shiigi S., Henry C., Chan E. Preparation of mouse cell suspensions. Selected Methods in Cellular Immunology, B. B. Mishell, S. M. Shiigi. Freeman, San Francisco 1980; 3–9; 24–25
   Google Scholar
• Duke R. C., Cohen J. J. Morphological and biochemical assays of apoptosis. Current Protocols in Immunology. Wyllie, New York 1992; 3.17.7–3.17.8
   Google Scholar
• Hansen M. B., Nielsen S. E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 1989; 119: 203–210
   PubMed Web of Science ®Google Scholar
• Swanson B. N., Newton D. L., Roller P. P., Sporn M. B. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents. J. Pharmacol. Exp. Ther. 1981; 219: 632–637
   PubMed Web of Science ®Google Scholar
• Thompson E. A. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel “slow death” phenotype. Cancer Res. 1991; 51: 5544–5550
   PubMed Web of Science ®Google Scholar
• Dillchay D. L., Li W., Kalin J., Walia A. S., Lamon E. W. In vitro effects of retinoids on murine thymus-dependent and thymus-independent mitogenesis. Cell. Immunol. 1987; 107: 130–137
   PubMed Web of Science ®Google Scholar
• Bunk M. J., Kinahan J. J., Sankar N. H. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells. Cancer Lett. 1985; 26: 319–326
   PubMed Web of Science ®Google Scholar
• Dillehay D. L., Shealy Y. F., Lamon E. W. Inhibition of moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids. Cancer Res. 1989; 49: 44–50
   PubMed Web of Science ®Google Scholar
• Evans R. M. The steroid and thyroid hormone receptor super-family. Science 1988; 240: 889–895
   PubMed Web of Science ®Google Scholar
• Chambon P. The molecular and genetic dissection of the retinoid signaling pathway. Recent Prog. Hormone Res. 1995; 50: 317–332
   PubMedGoogle Scholar
• Kazmi S. M., Plante R. K., Voisconti V., Lau C. Y. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoic receptor-mediated gene expression in human breast cancer cell lines. Cancer Res. 1996; 56: 1056–1062
   PubMed Web of Science ®Google Scholar